[ TRANSACTION RECORD ]

Warburg Pincus Investment in Simtra BioPharma Solutions — 2023

VERIFIED VECTOR ID: 001495 · tx-023
M SOURCE NODE — FUNDER
Warburg Pincus
Finance United States
$3,250,000,000
EQUITY
02/10/2023
Q DESTINATION NODE — RECIPIENT
Simtra BioPharma Solutions
Company United States
Amount (USD)
$3.3B
Flow Type
EQUITY
Transaction Date
02/10/2023
Primary Source
View Filing ↗
Funder Profile [ M ]
Entity Warburg Pincus
AUM 83000
HQ Location United States
Sector Finance
Recipient Profile [ Q ]
Entity Simtra BioPharma Solutions
Entity Type Company
Jurisdiction United States
Intelligence Note

Warburg Pincus and Advent International acquired Baxter’s BioPharma Solutions business for 3.25 billion dollars, rebranding it as Simtra BioPharma. This transaction focuses on expanding the company’s sterile manufacturing capabilities for the global pharmaceutical market. The deal represents a significant institutional investment in the healthcare supply chain.

Σ
Primary Forensic Source https://www.warburgpincus.com/2023/10/02/baxter-completes-sale-of-biopharma-solutions-business-to-advent-international-and-warburg-pincus/
✓ SOURCE LINKED